Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 29, 2015. The document serves as a notification of transactions involving Directors and Persons Discharging Managerial Responsibility (PDMR) under the UK Disclosure Guidance and Transparency Rules (DTR 3.1.4R(1)(a)).
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a disclosure of executive share option grants and does not contain financial performance data.
Material Changes
The material change disclosed is the grant of share options to specific Directors and PDMRs under the GlaxoSmithKline plc ShareSave Plan 2015. The options were granted on October 29, 2015, at an exercise price of £10.13 per share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the administrative notification of the share option grants.
Important Facts for Investors
- Option Grant Date: October 29, 2015.
- Exercise Price: £10.13 per Ordinary Share.
- Plan: GlaxoSmithKline plc ShareSave Plan 2015.
- Recipients and Allocation:
- Sir Andrew Witty: 888 options
- Mr R G Connor: 888 options
- Mr S Dingemans: 266 options
- Mr N Hirons: 888 options
- Mr D S Redfern: 888 options
- Mr P C Thomson: 533 options
- Dr P J T Vallance: 888 options
- Mrs V A Whyte: 888 options